2nd World RNA-Based Therapeutic & Vaccine Summit South Korea 2026

 

Driven by South Korea’s government making strategic investments in mRNA platforms and growing collaboration between global pharma and local biotech innovators, the field is experiencing renewed development momentum. This is placing the region as a key hotspot for global mRNA innovation and interest.

Uniquely positioned as the industry’s most comprehensive biopharma forum, the 2nd World RNA-Based Therapeutic & Vaccine Summit South Korea brings together global and local leaders to share first-hand insights into cutting-edge mRNA modalities, delivery technologies, and manufacturing excellence, to progress mRNA medicines to patients faster.

Join 90 leading players from large pharma including Sanofi, Eisai, and Meiji Seika Pharma to brand new biotechs such as Lemonex Bio, AceRNA Technologies, and BreezeBio to build future collaborations.

This event is part of the World Advanced Therapeutics Summit South Korea, so attendees will also have access to sessions for the World Cell & Gene Therapy Summit South Korea.

More Info

---

---